Zobrazeno 1 - 10
of 182
pro vyhledávání: '"intermediate-risk prostate cancer"'
Publikováno v:
Asian Journal of Andrology, Vol 26, Iss 6, Pp 549-556 (2024)
In this nonsystematic review of the literature, we explored the changing landscape of detection and treatment of low- and intermediate-risk prostate cancer (PCa). Through emphasizing improved cancer assessment with histology classification and genomi
Externí odkaz:
https://doaj.org/article/58c3f17e256043a7861008773612c3ce
Autor:
Antonio Benito Porcaro, Emanuele Serafin, Davide Brusa, Sonia Costantino, Claudio Brancelli, Maria Angela Cerruto, Alessandro Antonelli
Publikováno v:
Asian Journal of Andrology, Vol 26, Iss 6, Pp 569-574 (2024)
An enduring debate in research revolves around the association between elevated endogenous testosterone levels and prostate cancer. This systematic review is intended to assess the present understanding of the role of endogenous testosterone in the d
Externí odkaz:
https://doaj.org/article/4804151c9eab45b08a8eb307cb87e4c7
Autor:
Antonio Benito Porcaro, Francesca Montanaro, Alberto Baielli, Francesco Artoni, Claudio Brancelli, Sonia Costantino, Andrea Franceschini, Sebastian Gallina, Alberto Bianchi, Emanuele Serafin, Alessandro Veccia, Riccardo Rizzetto, Matteo Brunelli, Filippo Migliorini, Salvatore Siracusano, Maria Angela Cerruto, Riccardo Giuseppe Bertolo, Alessandro Antonelli
Publikováno v:
Asian Journal of Andrology, Vol 26, Iss 6, Pp 587-591 (2024)
The study aimed to test if Briganti’s 2012 nomogram could be associated with the risk of prostate cancer (PCa) progression in European Association of Urology (EAU) intermediate-risk patients treated with robotic surgery. From January 2013 to Decemb
Externí odkaz:
https://doaj.org/article/fcbe40db12a24840a27e39ff746bd36a
Autor:
David Pasquier, Philippe Nickers, Didier Peiffert, Philippe Maingon, Pascal Pommier, Thomas Lacornerie, Emmanuelle Tresch, Maël Barthoulot, Eric Lartigau
Publikováno v:
European Urology Open Science, Vol 54, Iss , Pp 80-87 (2023)
Background: Genitourinary (GU) or gastrointestinal (GI) complications and tumor relapse can occur in the long term after radiotherapy for prostate cancer. Objective: To assess the late tolerance and relapse-free survival (RFS) in patients undergoing
Externí odkaz:
https://doaj.org/article/ef790effe22f49c6b85858cadf3a5122
Autor:
Michael V. Sherer, Austin J. Leonard, Tyler J. Nelson, P. Travis Courtney, Kripa Guram, Gustavo Rodrigues De Moraes, Juan Javier-Desloges, Christopher Kane, Rana R. McKay, Brent S. Rose, Aditya Bagrodia
Publikováno v:
European Urology Open Science, Vol 50, Iss , Pp 61-67 (2023)
Background: Guidelines suggest that active surveillance (AS) may be considered for select patients with favorable intermediate-risk (fIR) prostate cancer. Objective: To compare the outcomes between fIR prostate cancer patients included by Gleason sco
Externí odkaz:
https://doaj.org/article/ce0a515b595e4192886bf1f947a77d45
Autor:
Irina Vierasu, Gaetan Van Simaeys, Nicola Trotta, Simon Lacroix, Guy Bormans, Simone Albisinni, Thierry Quackels, Thierry Roumeguère, Serge Goldman
Publikováno v:
European Journal of Hybrid Imaging, Vol 7, Iss 1, Pp 1-13 (2023)
Abstract Background Positron emission tomography/computed tomography (PET/CT) using radiotracers that bind to the prostate-specific membrane antigen (PSMA) is mainly used in biochemical recurring prostate cancer. The aim of our study was to assess th
Externí odkaz:
https://doaj.org/article/60eb4b0b2cc54313baf95b851d7f2cfc
Publikováno v:
Current Oncology, Vol 29, Iss 10, Pp 7964-7978 (2022)
Few studies have focused on the link between active surveillance (AS) and Gleason score upgrade (GSU) and its impact on the prognosis of patients with prostate cancer (PCa). This study aimed to analyze the effect of AS duration on GSU and prognostic
Externí odkaz:
https://doaj.org/article/fd4f812220bc43f4839b199e4bf10c58
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье, Vol 12, Iss 2, Pp 90-97 (2022)
Prostate cancer is in third place in the structure of mortality in men. The most significant factor influencing the tactics of treatment and the likelihood of tumor progression after radical treatment is the degree of tumor malignancy. The aim of the
Externí odkaz:
https://doaj.org/article/78b8786213a54f9abe2450853f01a54c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.